Proteins Do Not Predict Outcome Of Herceptin Treatment In HER2-Positive Breast Cancer
12/09/2011
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2-Positive Breast Cancer with Herceptin, say Mayo Clinic researchers...
What's In Your Stocking? Make Sure It's Not DVT
12/09/2011
Deep vein thrombosis (DVT) is a blood clot in the deep veins in the legs. These clots can break loose and travel to the lungs, causing a potentially fatal pulmonary embolism (PE). Even when they don't, they can cause permanent damage to the leg veins that results in long-term pain, swelling, and disability of the leg...
Unique Genetic Marker May Improve Detection Of Recurrent Ovarian Cancer
12/09/2011
Ovarian cancer is a major health concern for women and the identification of sensitive biomarkers for early detection and/or monitoring of disease recurrence is of high clinical relevance. New work published in the online journal PLoS ONE reports promising advances toward the development of blood-based DNA markers for ovarian cancer. The researchers, led by Peter W...
Closing In On An Ulcer- And Cancer-Causing Bacterium
12/09/2011
A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has been implicated in stomach cancer has managed for eons to turn the acidic environment of the human gut into one in which it can thrive...
Experimental Drug Targets Breast Cancer Stem Cells
12/09/2011
In a novel therapeutic approach to treating breast cancer, Loyola University Medical Center researchers are reporting positive results from a clinical trial of a drug that targets tumor stem cells. Existing cancer drugs are effective in killing mature cancer cells. But a handful of cancer stem cells are resistant to such drugs. They survive and go on to develop into new tumor cells...
A Novel Strategy For Fighting Cancer Targets Secondary Tumors
12/09/2011
The proliferation of metastases is often the main cause of complications and death from cancer. For the first time, researchers are looking very closely at the development of these metastases themselves, instead of focusing on the "primary" cancers from which they originated...
The addition of zoledronic acid to adjuvant endocrine therapy increased bone mineral density and reduced the risk for disease recurrence among postmenopausal women with early hormone receptor-positive breast cancer, according to new data from the ZO-FAST trial. Richard de Boer, M.D...
Anastrozole With Fulvestrant Can Lengthen Lives Of Women With ER+ Metastatic Breast Cancer
12/09/2011
Post-menopausal women with hormone receptor-positive metastatic breast cancer may have a new treatment option that could lengthen their lives, according to results of a study by the SWOG clinical trials network that were presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium...
Starch Consumption Raises Risk Of Breast Cancer Coming Back
12/09/2011
Breast cancer survivors whose starch intake is above average have a greater risk of cancer recurrence compared to other breast cancer survivors, researchers from the University of California, San Diego explained at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 6-10, 2011. The researchers added that it is in particular starch that raises the risk, and not just overall carbohydrates...
Give Nuns The Pill For Health Reasons ?
12/08/2011
Women who have children have lower risks of breast, ovarian, and uterine cancer compared childless (nulliparous) women, so researchers have suggested the possibility of giving them the pill to regulate their menstrual cycles and statistically improve their health, rather than for contraceptive reasons...